Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Accuray Incorporated Stories

2012-06-13 14:23:31

SUNNYVALE, Calif., June 13, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Wells Fargo Healthcare Conference in Boston on Wednesday June 20, 2012 at 9:00 a.m. EDT/6:00 a.m. PDT. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com. The webcast replay of the presentation will begin...

2012-06-07 02:28:36

SUNNYVALE, Calif., June 7, 2012 /PRNewswire/-- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that outcome data on intermediate risk prostate cancer patients treated with CyberKnife® Prostate SBRT was presented at the American Urological Association Meeting (AUA) 2012 held in Atlanta, Ga. The prospective monotherapy study, titled, "Four Year Outcomes and Quality of Life Following Stereotactic Body Radiation Therapy: A Rapid, Non-Invasive...

2012-05-30 06:26:31

SUNNYVALE, Calif., May 30, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Jefferies Global Healthcare Conference in New York on Thursday, June 7, 2012 at 11:30 a.m. EDT/8:30 a.m. PDT. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com. The webcast replay of the presentation will...

2012-05-22 02:27:34

SUNNYVALE, Calif., May 22, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the signing of a multi-year master research and collaboration agreement with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) a luminary research institution located in Heidelberg, Germany. Accuray and DKFZ will collaborate on cutting-edge research in radiation oncology to advance treatment technology and provide health care...

2012-05-17 02:26:02

SUNNYVALE, Calif., May 17, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the appointment of Richard Pettingill, LFACHE as a member of the company's Board of Directors effective May 11, 2012. Richard Pettingill's career as a healthcare executive spans four decades and includes leadership positions in a variety of prominent organizations. Most recently, Pettingill, who is a Lifetime Fellow of the American College of...

2012-05-15 02:29:53

SUNNYVALE, Calif., May 15, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the B. Riley & Company 13th Annual Investor Conference in Los Angeles on Wednesday, May 23, 2012 at 11:30 a.m. PDT/2:30 p.m. EDT. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com. The webcast replay of the...

2012-05-09 02:27:06

SUNNYVALE, Calif., May 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the availability of VoLO(TM) Technology for the TomoTherapy® System, a new treatment planning system that leverages advanced graphics processing technology and a new calculation algorithm to increase clinical efficiency, throughput and flexibility in developing even the most complex radiation plans. The new VoLO solution features...

2012-05-08 10:26:44

SUNNYVALE, Calif., May 8, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the third quarter of fiscal 2012 that ended March 31, 2012. The fiscal 2012 financial data presented below reflects Accuray's consolidated results including the results for TomoTherapy which was acquired by Accuray in June 2011. Non-GAAP results are provided to enhance understanding of Accuray's ongoing core results of operations....

2012-04-26 02:29:33

SUNNYVALE, Calif., April 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the launch of the Prostate Advances in Comparative Evidence (PACE) Study, an international, multi-center, randomized study to compare CyberKnife® Stereotactic Body Radiation Therapy (SBRT), da Vinci assisted and manual laparoscopic surgery and conventionally fractionated intensity modulated radiation therapy (IMRT), for the treatment of...

2012-04-09 02:24:09

SUNNYVALE, Calif., April 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its third quarter of fiscal year 2012, ended March 31, 2012 on Tuesday, May 8, 2012 after the market closes. A conference call to review the results of its third quarter of fiscal year 2012 will begin at 2:00 p.m. PDT/5:00 p.m. EDT and will be hosted by Euan S. Thomson, Ph.D., president and chief executive officer and...